Diabetes mellitus: A common disease with potentially severe consequences
MSD has made an important and innovative contribution to the treatment of type 2 diabetes mellitus
WHAT IS DIABETES MELLITUS TYPE 2?
Type 2 diabetes mellitus is a disease in which the metabolism of sugar is impaired.1
Type 2 diabetes mellitus is a chronic metabolic disorder that develops slowly and is characterized by abnormally elevated blood glucose levels. Type 2 diabetes mellitus develops when the pancreas does not produce enough insulin, or the body cannot use insulin effectively to convert blood sugar into energy (insulin resistance). To normalize high blood glucose levels, switching to a healthier diet and increasing exercise can help, but in many cases, this is not enough. 1
Thanks to ongoing research and development of new compounds, numerous medications are now available to lower blood glucose levels. As MSD, we are proud that our long-standing research program has helped to make an important and innovative contribution to the treatment of type 2 diabetes mellitus.
By 2045, it is expected that 629 million people worldwide could have diabetes mellitus. 2
In Austria, approximately 5-7% of the population has type 2 diabetes mellitus. 3
90% of all diabetes sufferers are affected by type 2 diabetes. 4
Diabetes is a leading cause of blindness, kidney failure, heart attack, stroke, and lower extremity amputation. 5
Topics and tips
You can find interesting topics and tips about diabetes on the website www.gesunder-lebensstil.at. This offers a lot of useful information about the causes, symptoms and treatment options of this disease. Furthermore, you can get helpful tips for a healthy lifestyle, quick recipes to try out from a dietician and short and effective sports exercises from a sports scientist to do at home. 6
Source 2: ÖDG: Austrian Diabetes Society. Diabetes mellitus - guidance for practice. Revised and expanded version 2019: Vienna; Klin Wochenschr 2019; Volume 131/Supplement 1, 2019.
Source 3: ÖDG: Austrian Diabetes Society. Diabetes mellitus - guidance for practice. Revised and expanded version 2019: Vienna; Klin Wochenschr 2019; Volume 131/Supplement 1, 2019.
AT-NON-01096, created October 2021